Medication Adherence Among Multimorbid Patients With Polypharmacy and Its Relation to Social Support at National Guard Primary Health Care Centers, Riyadh

• Published in: Curēus (Palo Alto, CA) Vol. 14; no. 10; p. e30679
• Main Authors: Almutairi, Ahmed S, Alhazmi, Taghreed M, Alotaibi, Yazeed H, Alfraidi, Abdulmajeed A, Alsaad, Abdulaziz M, Matrood, Rashed A, Al-Khatir, Abdulmohsen N, Alsubaie, Abdulrahman A, Alotibi, Waleed M
• Format: Journal Article
• Language: English
• Published: United States Cureus Inc 25-10-2022
• Subjects: Adults; Age; Chronic illnesses; Clinics; Comorbidity; Data analysis; Diabetes; Health care; Hypertension; Medicine; Military reserves; Older people; Patient compliance; Polypharmacy; Quality of life; Social support; Saudi Arabia; United States > US; social support; multimorbidity; medication; adherence; polypharmacy
• DOI: 10.7759/cureus.30679
• EISSN: 2168-8184

The aim of the present study was to estimate the prevalence of nonadherence to medication in multimorbid patients with polypharmacy and its relationship to social support in primary healthcare centers in Riyadh, Saudi Arabia.
We conducted a cross-sectional, convenience-sample, non-randomized study in three primary healthcare centers managed by National Guard Health Affairs. The participants included 417 adult patients - (a) with two or more chronic illnesses and (b) who were taking two or more medications. The primary outcome variable was the prevalence of medication nonadherence in multimorbid patients with polypharmacy as measured by the modified Morisky Medication Adherence Scale (MMAS-8). The second main variable was the impact of functional social support, as measured by the Duke-UNC Functional Social Support Questionnaire (FSSQ), on medication adherence.
The level of medication adherence was low for 194 (46.5%) of the 417 patients, medium for 127 (30.5%), and high for 96 (23%). There were 256 (61.4%) male participants and 161 (38.6%) females, and their mean age was 59.15 (SD ± 11.186) years. Additionally, 171 (41%) participants used two or three medications, 127 (30.5%) used four or five medications, and 119 (28.5%) used more than five medications; 178 (42.7%) of the patients had two comorbidities, 136 (32.9%) had three comorbidities, 69 (16.5%) had four comorbidities, and 31 (7.5%) had five comorbidities. Some social support data from the Duke-UNC Functional Social Support Questionnaire (FSSQ) was missing for 58 (13.9%) of the participants. Among the rest of the sample, reported levels of social support levels were high for 246 (59%) patients, medium for 101 (24.2%), and low for 12 (2.9%) patients. None of the differences between social support and medication adherence were statistically significant. However, 61 (24.8%) patients reported both high social support and high medication adherence; 173 (48.2%) had low social support and low medication adherence (p = 0.470).
We found that medication nonadherence in multimorbid patients with polypharmacy was high (46.5%). Although there were no statistically significant relationships between social support and medication adherence, certain patient characteristics were associated with low medication adherence - age over 60 years, male gender, and number of medications.